Remission of refractory hepatitis C-negative cryoglobulinaemic vasculitis after rituximab and infliximab

Nephrol Dial Transplant. 2005 Jan;20(1):213-6. doi: 10.1093/ndt/gfh564.

Authors

Maria Koukoulaki¹, Sumith C Abeygunasekara, Kenneth G C Smith, David R W Jayne

Affiliation

¹ The Vasculitis and SLE Unit, Department of Medicine, University of Cambridge School of Clinical Medicine, UK.

PMID: 15632353
DOI: 10.1093/ndt/gfh564

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't
Review

MeSH terms

Antibodies, Monoclonal / administration & dosage*
Antibodies, Monoclonal, Murine-Derived
Cryoglobulinemia / complications
Cryoglobulinemia / diagnosis
Cryoglobulinemia / drug therapy*
Dose-Response Relationship, Drug
Drug Administration Schedule
Drug Therapy, Combination
Female
Follow-Up Studies
Hepacivirus
Hepatitis C
Humans
Infliximab
Middle Aged
Risk Assessment
Rituximab
Treatment Outcome
Vasculitis / complications
Vasculitis / diagnosis
Vasculitis / drug therapy*

Substances

Antibodies, Monoclonal
Antibodies, Monoclonal, Murine-Derived
Rituximab
Infliximab